Retraction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model

Key Points

• The study was aimed at enhancing therapeutic effects on liver cancer using DOX–AuGCs.
• Results showed that DOX–AuGCs could improve treatment outcomes for liver cancer models.
• The initial findings indicated a significant improvement in therapeutic effectiveness with the nanoparticles.
• Retraction highlights the need for critical evaluation of published results in cancer therapy research.